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Background: Infection with Helicobacter pylori is considered a potential risk of developing gastric cancer in
association with contributing host genetic factor. IL-1b and IL-1RN polymorphisms appear to maintain and
promote Helicobacter pylori infection and to stimulate neoplastic growth of the gastric mucosa.
Objective and methods: In order to elucidate the effect of these polymorphisms in combination with gastric
cancer in a population from northwestern Algeria, a case-control study was carried out on 79 patients infected
with H. pylori with chronic atrophic gastritis and/or gastric carcinoma, and 32 subjects were recruited as case-
control. IL-1b-31 bi-allelic and IL-1b-511 bi-allelic polymorphisms and IL-1RN penta-allelic were genotyped.
Results: IL-1b-31C was associated with an increased risk of developing gastric carcinoma (OR4.614
[1.4314.81], p0.01). However, IL-1RN2 heterozygous allele type was significantly associated with chronic
atrophic gastritis (OR4.2 [1.233.61], p0.022). IL-1b-511T was associated with an increased risk of
development of chronic atrophic gastritis (OR4.286 [1.5411.89], p0.005).
Conclusion: IL-1b and IL-1RN polymorphisms associated with H. pylori infection contribute to the
development of chronic atrophic gastritis and gastric carcinomas in an Algerian population. The alleles
IL-1b-31C and IL-1RN were associated with an increased riskof developing gastric carcinoma, and IL-1b-511T
with an increased risk of developing chronic atrophic gastritis with no significant association of developing
gastric carcinoma.
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H
elicobacter pylori (H. pylori) infection of the
gastric mucosa is a worldwide pandemic in-
creasingly related to various gastric diseases
such as asymptomatic gastritis, peptic ulcers, and malig-
nant tumors (1). Based on the strongest association
between H. pylori and gastric cancer, the World Health
Organization has considered this germ as a class I car-
cinogen since 1994 (2). The global prevalence of gastric
cancer has increased from 1 to 3% among people infected
with H. pylori. Furthermore, the clinical outcomes
depend largely on the distribution and the severity of
the infection (3). The justification for such divergent
clinical outcomes is gradually revealed in the paradigm of
interaction between two pathways, gastric acid secretion
and gastritis induced by H. pylori (4). The ability and
localization of high gastric acid secretion determine
divergent diseases: a high acid secretion in response to
a predominant antral gastritis tends to result in peptic
ulcers, while low secretion with pangastritis tends to lead
to cancer gastric (4).
The IL-1 cluster IL-1b gene encoding IL-1b and the
IL-1RN gene coding for the anti-inflammatory antagonist
(IL-1ra) of IL-1 receptor are located on chromosome 2q14
and have a number of functionally relevant polymorphisms
that could be correlated with the high or low production
of IL-1b (58). Substitution in the promoter region
of the TATA box at the 511 position (CT; dbSNP:
rs16944) and the 31 position (TC; dbSNP: rs1143627)
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has been observed. The two single nucleotide polymorph-
isms (SNPs) are in linkage disequilibrium (9) by skewing
this interaction, causing an unfavorable IL-1b to IL-1RN
ratio (10). IL-1b is not only a determinant of a pro-
inflammatory phenotype but also appears to be a major
cofactor in maintaining and promoting H. pylori infection
(11). Individuals with gastric pro-inflammatory genotype
overexpressed IL-1b in response to H. pylori infection,
which leads to gastrin overexpression, increased gastric
inflammation, gastric atrophy, and hypochlorhydria, and
possibly stimulates neoplastic growth (10, 12). El-Omar
et al. were the first who reported that genotype IL-1b-
511T, IL-1b-31C, and IL-1RN 2/2 are associated with
an increased risk of developing gastric cancer (6). Their
findings among Scottish and Polish patients were then
confirmed by studies in other ethnic groups in Portugal (13),
USA (7), China (4), Japan (14), and Latin America (15).
Our study aims to evaluate the associations of these
polymorphisms in the presence of H. pylori infection of
the gastric mucosa in patients with gastric carcinoma




This study was conducted during 14 months (October 2014
to November 2015) on patients with AG (n39) and GC
(n40) at two medical oncology and gastroenterology
facilities in the northwestern region of Algeria. However,
32 other individuals were recruited as controls (HC).
All patients with chronic AG or GC were H. pylori
positive. The control group was H. pylori negative with no
family history of cancer. Infection with H. pylori was
confirmed by histopathology of biopsies sampled during
diagnostic endoscopy (at least four biopsies of the antrum
and body gastric mucosa should be available for each case)
and anti-HP IgG serum antibody tests. The corresponding
tissue sections were stained for slide reading in the
anatomopathology department of the University Hospital
of Sidi-Bel-Abbes, Algeria.
The existence of H. pylori DNA in gastric biopsies and
buccal swabs were analyzed by PCR amplification of the
ureC gene using primers as described by Lage et al. (16)
(forward: 5?-AAGCTTTTAGGGGTGTTAGGGGTTT-
3? and reverse: 5?-AAGCTTACTTTCTAACACTAACG
C-3?) at a hybridization temperature of 558C. We employed
a DNA volume of 25 ml according to PCR criteria, as
described below. The amplified fragments were visualized
by using the GelRedTM Nucleic Acid Gel Stain, 10,000 X
(Biotium, Hayward, CA, USA), and 2.5% agarose gel. The
obtained fragments were of 294 bp.
Information about personal data, sociodemographic
characteristics, educational level, blood type, rhesus factor,
eating habits, smoking, and alcohol consumption were
evaluated using a predetermined questionnaire. Further-
more, all participants gave their consent after the study
protocol had been explained to them.
Considering Decree No. 387 (article 25) dated 31 July
2006 about ethical trials in Algeria, we obtained the
required access authorizations to the concerned health
facilities in order to accomplish our study protocol.
Furthermore, we obtained informed written consent
from all participants and their treating physicians after
the study protocol had been explained to them.
Analysis of IL-1b-31, IL-1b-511, and IL-1RN
polymorphisms
IL-1b-31 and IL-1b-511 polymorphisms are single nucleo-
tide changes in the promoter region, while the IL-1RN
polymorphism is a repetition of 86 bp in the second intron.
The DNA was extracted from 200 ml whole blood samples,
20 mg of fresh gastric biopsy, or buccal swab in H. pylori
transport medium using an extraction kit (MagaZorbe†
genomic DNA, Promega, Fitchburg, Wisconsin, USA)
stored at 208C. Genotyping of the two polymorphisms
(IL-1b-31 and IL-1b-511) was performed using the restric-
tion fragment length polymorphism method (PCR-RFLP)
(Table 1) (6, 10). Briefly, 2550 ng of DNA was used in a
volume of 25 ml with 150 mM dNTP, 6.25 pmol of each
primer, 1 U of DNA polymerase GoTaq† G2 Hot start
polymerase (Promega, Fitchburg, Wisconsin, USA), 5%
DMSO, 4 mM MgCl2, and 5 ml of 5x PCR buffer GoTaq.
The amplified/digested fragments were visualized with the
GelRedTM Nucleic Acid Gel Stain, 10,000 X (Biotium,
Hayward, CA, USA) in 2.5% agarose gel.
Variable numbers of tandem repeats (VNTR) analysis in
the second intron of the IL-1RN gene was carried out by
PCR. The different alleles were identified by the size of
the PCR fragments and encoded in a conventional manner
(6, 13) as follows: allele 1 (four repetitions), allele 2 (two
repetitions), allele 3 (five repetitions), allele 4 (three
repetitions), and allele 5 (six repetitions). According
to previous studies (6, 13), as described in Table 1, the
IL-1RN alleles were dichotomized into two categories:
long genotype (L:three repetitions; alleles 1, 3, 4, 5) and
short genotype (2: two repetitions; allele 2).
Statistical analysis
Data were processed and analyzed using SPSS 22.0
(Statistical Package for the Social Sciences, IBM Cor-
poration; Chicago, IL, August 2013). Chi-square test was
used to evaluate differences in the distribution of poly-
morphisms between different groups. All allelic distribu-
tions were examined for the corresponding differences of
their Hardy-Weinberg equilibrium. The relative risk was
evaluated by multivariate logistic regression based on
categorical reference predictor models, adjusting for sex
and age with a confidence interval (CI) of 95% and
statistical significance set at pB0.05. Allelic combina-
tions of models of the three variants closely related
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polymorphisms of IL-1b and IL-1RN were analyzed. The
study of the haplotypes and linkage disequilibrium
between loci (estimated by r2 and D?) was carried out
via the web interface in the LinkDos (www.genepop.curtin.
edu.au/linkC.html).
Results
The mean age of all participants was 45.0917.67 years,
and ranged from 16 to 86 years. In healthy individuals, the
mean age was 35.8912.72 years with a male-to-female
ratio of 1:1 (Table 2). However, in patients with AG and/or
GC, mean ages were 49.3919.35 (male-to-female ratio of
0.56:1) and 59.3914.00 years (male-to-female ratio of
2.27:1), respectively.
The frequencies of the tested genotypes were in Hardy-
Weinberg disequilibrium according to the following
results.
Linkage disequilibrium analysis between IL-1b-31 and
IL-1b-511 for AG patients gave the following results:
r20.6804, D?0.46294; moreover, analysis of linkage
disequilibrium between IL-1b-31 and IL-1b-511 in GC
patients: r20.69357, D?0.48.
Considering the whole studied population, IL-1RN was
positively correlated (r0.424, r20.180) with IL-1b-31
(p0.023) andwith IL-1b-511 (p0.006). In patients with
GC, we noticed weak positive correlations (r0.377,
r20.142) of IL-1RN with IL-1b-31 (p0.550) and
IL-1b-511 (p0.056), respectively.
Non-significant correlations (r0.454, r20.206) be-
tween IL-1RN, on the one hand, and IL-1b-31 (p0.703)
and IL-1b -511 (p0.072), on the other hand, were
observed in patients with AG. Nevertheless, the correla-
tions were non-significant in healthy subjects (p0.134 for
IL-1b-31 and p0.058 for IL-1b-511).
As depicted in Table 3, the frequency of L/L wild-type
pattern of IL-1RN was 87.5% in controls compared to
62.5% in GC and 82.1% in AG patients. The IL-1RN2
allele rates, for either heterozygous or homozygous, were
37.5% in GC, 17.9% in AG, and 12.5% in controls.
Regarding the IL-1b-511, the proportions of C/C wild-
type pattern were 56.3% in healthy subjects, 47.5% in GC,
and 23.1% in AG patients. Individuals carrying the allele
IL-1b-511T are represented by 76.9% of AG, 52.5% of
GC, and 43.8% of healthy controls.
Table 1. Primers and conditions for analysis of the IL-1b and IL-1RN polymorphisms
Polymorphism Primers Tm; PCR method (restriction enzyme); and definition of the allele
IL-1b31 Forward: 5?-TCTTTTCCCCTTTCCTTTAACT-3?
Reverse: 5?-GAGAGACTCCCTTAGCACCTAGT-3?
528C. PCR-RFLP (AluI); C allele: 234 bp; T allele:
150 bp and 84 bp
IL-1b511 Forward: 5?-CTGCATACCGTATGTTCTCTGCC-3?
Reverse: 5?-GGAATCTTCCCACTTACAGATGG-3?
598C. PCR-RFLP (DdeI); C allele: 140 bp and 49 bp;
T allele: 109 bp, 49 bp and 31 bp
IL-1RN Forward: 5?-FCTCAGCAACACTCCTAT-3?
Reverse: 5?-TCCTGGTCTGCAGGTAA-3?
608C; PCR; 2-repeat allele: 240 bp, 3-repeat allele:
326 bp; 4-repeat allele: 412; 5-repeat allele: 498 bp
Tm: melting temperature; IL-1b-31: cluster of gene encoding interleukin-1b in the promoter region of TATA box at the 31 position; IL-1b-
511: cluster of gene encoding interleukin-1b in the promoter region of TATA box at the 511 position; IL-1RN: gene encoding the anti-
inflammatory antagonist (interleukin-1ra).
Table 2. Comparison between groups according to gender
HC AG GC x2 p*
Female 16 (29.1%) 25 (45.5%) 14 (25.5%)
Male 16 (28.6%) 14 (25.0%) 26 (46.4%) 6.694 B0.05
Total 32 (28.8%) 39 (35.1%) 40 (36.0%)
AG: atrophic gastritis; GC: gastric carcinoma; HC: healthy controls;
(*) comparison between the three groups using Chi-square test.
Table 3. Distribution of the genotypes in the study population
Genotype HC n (%) All n (%) AG n (%) GC n (%)
IL-1RN
L/L 28 (87.50) 57 (72.15) 32 (82.05) 25 (62.50)
2/L 04 (12.50) 19 (24.05) 04 (10.25) 15 (37.50)
2/2 00 (00.00) 03 (03.79) 03 (07.69) 00 (00.00)
2/L2/2 04 (12.50) 22 (27.84) 07 (17.94) 15 (37.50)
IL-1B-511
C/C 18 (56.25) 28 (35.44) 09 (23.07) 19 (47.50)
T/C 14 (43.75) 22 (27.84) 09 (23.07) 13 (32.50)
T/T 00 (00.00) 29 (36.70) 21 (53.84) 08 (20.00)
T/CT/T 14 (43.75) 51 (64.55) 30 (76.92) 21 (52.50)
IL-1B-31
T/T 17 (53.12) 24 (30.37) 14 (35.89) 10 (25.00)
C/T 07 (21.87) 33 (41.77) 14 (35.89) 19 (47.50)
C/C 08 (25.00) 22 (27.84) 11 (28.20) 11 (27.50)
C/TC/C 15 (46.87) 55 (69.62) 25 (64.10) 30 (75.00)
AG: atrophic gastritis; GC: gastric carcinoma; All: atrophic
gastritis and gastric carcinoma; HC: healthy controls; IL-1b-31:
cluster in gene encoding interleukin-1b in the promoter region of
TATA box at the -31 position; IL-1b-511: cluster in gene encoding
interleukin-1b in the promoter region of TATA box at the 511
position; IL-1RN: gene encoding for the anti-inflammatory
antagonist (interleukin-1ra); L: long genotype (more than three
repetitions; alleles 1, 3, 4, 5); 2: short genotype (two repetitions;
allele 2); C or T: single nucleotide polymorphisms.
Effect of IL-1b and IL-1RN polymorphisms
Citation: Libyan Journal of Medicine 2016, 11: 31576 - http://dx.doi.org/10.3402/ljm.v11.31576 3
(page number not for citation purpose)
Our results show that 53.1% of healthy subjects, 35.9%
of patients with AG, and 25.0% of patients with GC have
the T/T wild-type pattern of IL-1b-31.
As illustrated in Table 4, we investigated major
genotypes implicated as risk factors for having GC and
AG compared to controls. When multivariate logistic
regression analysis was performed, our results showed
that the C/C homozygous 4.614 (95% CI, 1.43714.817)
and the C/T heterozygous 1.974 (95% CI, 0.5626.939)
genotypes of the IL-1b-31 each indicated a strong
contribution to GC. Likewise, the same genotypes have
non-significant risk of having AG (C/C: 2.429 [95% CI,
0.7697.673] and C/T: 1.455 [95% CI, 0.4025.260]).
However, the association between the two homozygous
and heterozygous genotypes C/T and T/T of IL-1b -511
was 4.286 (95% CI, 1.54411.898) times more at risk of
having AG compared to controls.
Concerning the heterozygous genotype L/2 of IL-1RN,
our findings show that the odds ratio of having GC was
4.200 (95% CI, 1.23014.337).
Table 4. Regression analysis of the distribution of the genotypes in the study
Multivariate logistic regression analysis p OR (95% CI)
GC * HC IL-1b (31) T/T 0.035 Reference
C/C 0.010 4.614 (1.43714.817)
C/T 0.289 1.974 (0.5626.939)
C/TC/C 0.016 3.400 (1.2549.216)
IL-1b (511) C/C 0.968 Reference
T/T 0.800 0.880 (0.3262.374)
C/T 0.999 0.000 (  )
C/TT/T 0.461 1.421 (0.5583.617)
IL-1RN L/L  Reference
L/2 0.022 4.200 (1.23014.337)
L/22/2 0.022 4.200 (1.23014.337)
AG * HC IL-1b (31) T/T 0.303 Reference
C/C 0.131 2.429 (0.7697.673)
C/T 0.568 1.455 (0.4025.260)
C/TC/C 0.148 0.494 (0.1901.283)
IL-1b (511) C/C 0.914 Reference
T/T 0.671 1.286 (0.4044.094)
C/T 0.998 0.000 (  )
C/TT/T 0.005 4.286 (1.54411.898)
IL-1RN L/L 0.984 Reference
L/2 0.999 0.000 (  )
2/2 0.859 0.875 (0.2003.828)
AG * GC IL-1b (31) T/T 0.497 Reference
C/C 0.238 0.526 (0.1811.527)
C/T 0.581 0.737 (0.2492.178)
C/TC/C 0.294 0.595 (0.2261.570)
IL-1b (511) C/C 0.009 Reference
T/T 0.522 1.462 (0.4574.674)
C/T 0.026 0.264 (0.0810.856)
C/TT/T 0.026 3.016 (1.1447.952)
IL-1RN L/L 0.042 Reference
L/2 0.999 0.000 (  )
2/2 0.012 0.208 (0.0610.706)
L/22/2 0.057 0.365 (0.1291.030)
AG: atrophic gastritis; GC: gastric carcinoma; HC: healthy controls; OR: odds ratio. GC * HC: regression analysis of combined gastric
carcinoma and healthy controls, AG * HC: regression analysis of combined atrophic gastritis and healthy controls, AG * GC: regression
analysis of combined atrophic gastritis and gastric carcinoma.
IL-1b-31: cluster in gene encoding interleukin-1b in the promoter region of TATA box at the 31 position; IL-1b-511: cluster in gene
encoding interleukin-1b in the promoter region of TATA box at the 511 position; IL-1RN: gene encoding the anti-inflammatory antagonist
(interleukin-1ra); L: long genotype (more than three repetitions; alleles 1, 3, 4, 5); 2: short genotype (two repetitions; allele 2); C or T: single
nucleotide polymorphisms.
Amine El-Mokhtar Drici et al.
4
(page number not for citation purpose)
Citation: Libyan Journal of Medicine 2016, 11: 31576 - http://dx.doi.org/10.3402/ljm.v11.31576
Further analysis of combined genotype between IL-1RN
and IL-1b-31 (Table 5) and IL-1RN and IL-1b-511 (Table 6)
was performed using x2 test. The association between
IL-1b-31 and IL-1RN was significant in AG patients
(p0.028) and in controls (p0.021). Furthermore, the
relationship between IL-1RN and IL-1b-511 was signifi-
cant for the same groups (AG: p0.014, and HC:
p0.015).
Discussion
The paradigm of previous studies on GC with regard
to different haplotypes of IL-1RN and IL-1b has been
investigated since 2000 on Scottish and Polish populations
(6, 7). The genotype carriers of homozygous IL-1b-31C
and IL-1RN2 have a high risk of hypochlorhydria as a
result of H. pylori infection with evidence for genetic
environmental interaction at an early stage of gastric
cancer (6). Machado et al. (13) reported results on a
Portuguese population by studying the etiological role of
IL-1b-511T allele, IL-1RN2 allele, and their association
with an increased risk of developing intestinal GC. Until
now, polymorphisms in genes of the pro-inflammatory
cytokines IL-1b and TNF-a constitute an increased risk of
developing GC in different gastric anatomical sites when
the patients’ ethnicity is not considered (1719).
Several studies on the association between IL-1b and
the IL-1RN genotype in Asian and Caucasian popula-
tions show that IL-1b-511T is significantly associated
with the risk of GC (20). Other studies showed that
IL-1b-511T and IL-1RN2 were associated with an
increased risk of developing GC in Caucasians. Similarly,
a significantly increased risk was noticed when analyses
showed positive associated with H. pylori infection with a
moderate increase among Hispanics, but not among
Asians (15, 2123).
To the best of our knowledge, only one study on the
IL-1b and IL-1RN polymorphisms and their association
with gastric cancer was performed in an Arab population,
namely in Oman. One hundred eighteen GC cases and
245 controls were compared. The authors found that the
IL-1RN2 polymorphism increases the risk of GC, but the
IL-1b-31C allele was not associated with the risk of
developing GC (24). In Africa, Kimang’a studied the
association of these polymorphisms with H. pylori
infection with different pathologies of the gastric mucosa
without considering GC. He reported a significant effect
of the IL-1b-511T allele on gastritis, gastrointestinal
reflux and gastric ulcers (25).
In this study, we evaluated the association between
IL-1b and IL-1RN VNTR polymorphisms and the risk of
AG and CG in northwestern Algeria. According to
GLOBOCAN 2012, GC is the fourth most common
cancer (both genders) in Algeria, with about 686 cases
per year (26). Our results show that the IL-1b-31C allele
is associated with an increased risk of developing GC
(OR4.614; p0.01). The IL-1RN2 heterozygous allele
Table 5. Distribution of genotypes among patient groups
IL-1b-31 n (%)
Sample type T/T C/C C/T Total Chi-square test (p)
AG IL-1RN L/L 14 (43.8) 08 (25.0) 10 (31.2) 32 (100.0) 0.028
L/2 00 (00.0) 03 (75.0) 01 (25.0) 04 (100.0)
2/2 00 (00.0) 00 (00.0) 03 (100.0) 03 (100.0)
Total 14 (35.9) 11 (28.2) 14 (35.9) 39 (100.0)
GC IL-1RN L/L 07 (28.0) 09 (36.0) 09 (36.0) 25 (100.0) 0.146
L/2 03 (20.0) 02 (13.3) 10 (66.7) 15 (100.0)
Total 10 (25.0) 11 (27.5) 19 (47.5) 40 (100.0)
HC IL-1RN L/L 16 (57.1) 08 (28.6) 04 (14.3) 28 (100.0) 0.021
L/2 01 (25.0) 00 (00.0) 03 (75.0) 04 (100.0)
Total 17 (53.1) 08 (25.0) 07 (21.9) 32 (100.0)
Total IL-1RN L/L 37 (43.5) 25 (29.4) 23 (27.1) 85 (100.0) 0.005
L/2 04 (17.4) 05 (21.7) 14 (60.9) 23 (100.0)
2/2 00 (00.0) 00 (00.0) 03 (100.0) 03 (100.0)
Total 41 (36.9) 30 (27.0) 40 (36.0) 111 (100.0)
Regression analysis of combined (IL-1RN vs. IL-1b-31) Chi-square test. AG: atrophic gastritis; GC: gastric carcinoma; HC: healthy
controls; IL-1b-31: cluster in gene encoding interleukin-1b in the promoter region of TATA box at the 31 position; IL-1b-511: cluster in
gene encoding interleukin-1b in the promoter region of TATA box at the 511 position; IL-1RN: gene encoding for the anti-inflammatory
antagonist (interleukin-1ra); L: long genotype (more than three repetitions; alleles 1, 3, 4, 5); 2: short genotype (two repetitions; allele 2);
C or T: single nucleotide polymorphisms.
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type is significantly associated with AG (OR4.2;
p0.022). These findings are in concordance with results
on Caucasians but different from those of Asian and
Arab populations in Oman (24, 27).
Considering the IL-1b-511T allele, no significant effect
on GC was noticed in the studied patients. This result is
in agreement with studies on Japanese and Korean
populations (27, 28), but different from results from
Caucasian populations (7, 13).
Individuals carrying the IL-1b-511T allele have more
risk of developing AG (OR4.286; p0.005) than GC.
The same findings were observed in a German popula-
tion (29). Contrariwise, in a recent study from Mexico,
individuals carrying IL-1b-511C and IL-1b-31T alleles
separately are more likely to develop AG and gastric
ulcers (30).
One limitation of the present study is the small sample
size. Moreover, this work investigated the association
between H. pylori infection and polymorphisms in only
two genes, IL-1b and IL-1RN, without invoking other
carcinogenic factors; this could be considered as another
limitation.
In conclusion, the presence of IL-1b and IL-1RN
polymorphisms with H. pylori infection of the gastric
mucosa contributes to the development of chronic AG
and GCs in an Algerian population. Individuals carrying
the IL-1b-31C and IL-1RN2 alleles are more likely to
have an increased risk of developing GC. On the other
hand, there is a positive correlation between chronic AG
and IL-1b-511T. These results highlight the importance
of ethnicity studies about the effect of IL-1b and IL-1RN
polymorphisms associated with H. pylori infection on
gastric carcinogenesis. Thus, large investigations needed
to gain a proper understanding of gastric mucosa
carcinogenesis in our region.
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